tirzepatide month 2 (Mounjaro) In Sherman Oaks Side by side after 3

Certain amounts are permissible under the law as long as the compounding is not done regularly or in inordinate amounts. Section 503B of the FD&C Act restricts outsourcing facilities from making compounded drugs that are essentially a copy of one or more FDA-approved drugs

Patchy darkening isolated to specific areas (e.g., one limb darker than the other despite equal UV exposure) suggests injection site rotation issues if administering subcutaneously to the same region repeatedly

Consistency matters more than the specific time of day, as semaglutide's effects build over multiple weeks rather than requiring precise hourly timing

Isnt this outside my scope as a psychiatrist? Scope is about competency, not tradition